These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 36378252)

  • 1. Prognostic value of tumor-to-parenchymal contrast enhancement ratio on portal venous-phase CT in pancreatic neuroendocrine neoplasms.
    Park HJ; Kim HJ; Kim JH; Kim SY; Choi SH; Byun JH; Kim SC; Hwang HS; Hong SM
    Eur Radiol; 2023 Apr; 33(4):2713-2724. PubMed ID: 36378252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of CT-based radiomics in grade 1-2 pancreatic neuroendocrine tumors.
    Heo S; Park HJ; Kim HJ; Kim JH; Park SY; Kim KW; Kim SY; Choi SH; Byun JH; Kim SC; Hwang HS; Hong SM
    Cancer Imaging; 2024 Feb; 24(1):28. PubMed ID: 38395973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison between neuroendocrine carcinomas and well-differentiated neuroendocrine tumors of the pancreas using dynamic enhanced CT.
    Park HJ; Kim HJ; Kim KW; Kim SY; Choi SH; You MW; Hwang HS; Hong SM
    Eur Radiol; 2020 Sep; 30(9):4772-4782. PubMed ID: 32346794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of WHO Classifications (2004, 2010), the Hochwald grading system, and AJCC and ENETS staging systems in predicting prognosis in locoregional well-differentiated pancreatic neuroendocrine tumors.
    Liu TC; Hamilton N; Hawkins W; Gao F; Cao D
    Am J Surg Pathol; 2013 Jun; 37(6):853-9. PubMed ID: 23598967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of CT findings to predict survival outcomes in patients with pancreatic neuroendocrine neoplasms: a single institutional study of 161 patients.
    Kim DW; Kim HJ; Kim KW; Byun JH; Kim SY; Song KB; Ramaiya NH; Tirumani SH; Hong SM
    Eur Radiol; 2016 May; 26(5):1320-9. PubMed ID: 26253259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of the characteristics of aggressiveness of pancreatic neuroendocrine neoplasms (PanNENs) based on CT radiomic features.
    Mori M; Palumbo D; Muffatti F; Partelli S; Mushtaq J; Andreasi V; Prato F; Ubeira MG; Palazzo G; Falconi M; Fiorino C; De Cobelli F
    Eur Radiol; 2023 Jun; 33(6):4412-4421. PubMed ID: 36547673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serotonin immunoreactive pancreatic neuroendocrine neoplasm associated with main pancreatic duct dilation: a recognizable entity with excellent long-term outcome.
    Dioguardi Burgio M; Cros J; Panvini N; Depoilly T; Couvelard A; Ruszniewski P; de Mestier L; Hentic O; Sauvanet A; Dokmak S; Faccinetto A; Ronot M; Vilgrain V
    Eur Radiol; 2021 Nov; 31(11):8671-8681. PubMed ID: 33977308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of postoperative recurrence in resectable pancreatic body/tail adenocarcinoma: a novel risk stratification approach using a CT-based nomogram.
    Xie T; Xie X; Liu W; Chen L; Liu K; Zhou Z
    Eur Radiol; 2023 Nov; 33(11):7782-7793. PubMed ID: 37624415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survivals of patients with surgically treated and High-grade pancreatic neuroendocrine carcinomas: A comparative study between two American Joint Committee on Cancer 8th tumor-node-metastasis staging systems.
    Yang M; Zhang Y; Zeng L; Ke NW; Tan CL; Tian BL; Xiang B; Liu XB
    Eur J Surg Oncol; 2019 Jun; 45(6):1054-1060. PubMed ID: 30661921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Eighth Edition of the American Joint Committee on Cancer Distant Metastases Stage Classification for Metastatic Pancreatic Neuroendocrine Tumors Might Be Feasible for Metastatic Pancreatic Ductal Adenocarcinomas.
    Wen J; Chen J; Liu D; Xu X; Fan M; Zhang Z
    Neuroendocrinology; 2020; 110(5):364-376. PubMed ID: 31357196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survivals of patients with pancreatic neuroendocrine carcinomas: An in-depth analysis by the American Joint Committee on Cancer 8th tumor-node-metastasis staging manual.
    Deng BY; Yang M; Wen JY; Hou SZ; Chen Y; Tian BL; Liu XB; Zhang Y
    Medicine (Baltimore); 2020 Jan; 99(3):e18736. PubMed ID: 32011453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relapse-free survival in patients with nonmetastatic, surgically resected pancreatic neuroendocrine tumors: an analysis of the AJCC and ENETS staging classifications.
    Strosberg JR; Cheema A; Weber JM; Ghayouri M; Han G; Hodul PJ; Kvols LK
    Ann Surg; 2012 Aug; 256(2):321-5. PubMed ID: 22415420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contrast-enhancement ratio on multiphase enhanced computed tomography predicts recurrence of pancreatic neuroendocrine tumor after curative resection.
    Arai T; Kobayashi A; Fujinaga Y; Yokoyama T; Shimizu A; Motoyama H; Kitagawa N; Notake T; Shirota T; Fukushima K; Masuo H; Kadoya M; Miyagawa S
    Pancreatology; 2016; 16(3):397-402. PubMed ID: 26850565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Number of Positive Lymph Nodes Is Superior to LNR and LODDS for Predicting the Prognosis of Pancreatic Neuroendocrine Neoplasms.
    Gao B; Zhou D; Qian X; Jiang Y; Liu Z; Zhang W; Wang W
    Front Endocrinol (Lausanne); 2021; 12():613755. PubMed ID: 33746899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pancreatic neuroendocrine tumors: Correlation between the contrast-enhanced computed tomography features and the pathological tumor grade.
    Takumi K; Fukukura Y; Higashi M; Ideue J; Umanodan T; Hakamada H; Kanetsuki I; Yoshiura T
    Eur J Radiol; 2015 Aug; 84(8):1436-1443. PubMed ID: 26022520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative prediction of postsurgical outcomes in mass-forming intrahepatic cholangiocarcinoma based on clinical, radiologic, and radiomics features.
    Park HJ; Park B; Park SY; Choi SH; Rhee H; Park JH; Cho ES; Yeom SK; Park S; Park MS; Lee SS
    Eur Radiol; 2021 Nov; 31(11):8638-8648. PubMed ID: 33890153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Competitive Testing of the WHO 2010 versus the WHO 2017 Grading of Pancreatic Neuroendocrine Neoplasms: Data from a Large International Cohort Study.
    Rindi G; Klersy C; Albarello L; Baudin E; Bianchi A; Buchler MW; Caplin M; Couvelard A; Cros J; de Herder WW; Delle Fave G; Doglioni C; Federspiel B; Fischer L; Fusai G; Gavazzi F; Hansen CP; Inzani F; Jann H; Komminoth P; Knigge UP; Landoni L; La Rosa S; Lawlor RT; Luong TV; Marinoni I; Panzuto F; Pape UF; Partelli S; Perren A; Rinzivillo M; Rubini C; Ruszniewski P; Scarpa A; Schmitt A; Schinzari G; Scoazec JY; Sessa F; Solcia E; Spaggiari P; Toumpanakis C; Vanoli A; Wiedenmann B; Zamboni G; Zandee WT; Zerbi A; Falconi M
    Neuroendocrinology; 2018; 107(4):375-386. PubMed ID: 30300897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and Assessment of a Clinical Calculator for Estimating the Likelihood of Recurrence and Survival Among Patients With Locally Advanced Rectal Cancer Treated With Chemotherapy, Radiotherapy, and Surgery.
    Weiser MR; Chou JF; Keshinro A; Chapman WC; Bauer PS; Mutch MG; Parikh PJ; Cercek A; Saltz LB; Gollub MJ; Romesser PB; Crane CH; Shia J; Markowitz AJ; Garcia-Aguilar J; Gönen M;
    JAMA Netw Open; 2021 Nov; 4(11):e2133457. PubMed ID: 34748003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic Value of Metabolic Tumor Volume and Total Lesion Glycolysis on Preoperative ¹⁸F-FDG PET/CT in Patients with Pancreatic Cancer.
    Lee JW; Kang CM; Choi HJ; Lee WJ; Song SY; Lee JH; Lee JD
    J Nucl Med; 2014 Jun; 55(6):898-904. PubMed ID: 24711649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Validity of the American Joint Committee on Cancer and the European Neuroendocrine Tumors Staging Classifications for Pancreatic Neuroendocrine Tumors: A Retrospective Nationwide Multicenter Study in South Korea.
    Cho JH; Ryu JK; Song SY; Hwang JH; Lee DK; Woo SM; Joo YE; Jeong S; Lee SO; Park BK; Cheon YK; Han J; Kim TN; Lee JK; Moon SH; Kim H; Park ET; Hwang JC; Kim TH; Jeon TJ; Cho CM; Choi HS; Lee WJ
    Pancreas; 2016 Aug; 45(7):941-6. PubMed ID: 26765964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.